Heading to the BIO Investor Forum  #BIF23? Be sure to check out Wednesday's 2pm session, hosted by Ruchita Sinha of @VenturesAv8 and featuring our founder Raphael Townshend @raphaeljlt https://bif.bio.org/bif-october-2023/ai-computational-biology-reach-undruggable-targets-1

📢Announcing a new addition to Atomic's leadership team: We're thrilled to welcome Manjunath Ramarao as Chief Scientific Officer. Dr. Ramarao adds >20 years in #biopharma research experience to our team, and we're excited to have him onboard. https://www.businesswire.com/news/home/20231011060063/en/Atomic-AI-Adds-Bristol-Myers-Squibb-Veteran-Dr.-Manjunath-Ramarao-as-Chief-Scientific-Officer

Adding our congratulations to @kkariko and @WeissmanLab for this year’s @NobelPrize in Physiology and Medicine. Great news for #RNA research and the future of #RNAtherapuetics!

R to @AtomicAICo: We you were kind of on our radar with that kind of funding. For sure!

Thanks to Tobias Jensen and @AISupremacyNews for featuring Atomic AI as one of six "mind-bendingly exciting" #AI startups. We're honored to be included. https://aisupremacy.substack.com/p/six-of-the-best-funded-ai-startups

With AI and experimental biology in harmony, we're creating a future where "undruggable" diseases meet their match. 💥💉 Learn more about our novel approach to RNA #drugdiscovery: https://atomic.ai/

🔍🧬 At Atomic AI, we're not just pushing boundaries – we're shattering them. Our proprietary AI-driven platform fuses machine learning and structural biology, propelling RNA drug discovery into a new era. 🌍🔬 Join us: https://atomic.ai/careers

Can crystal structures fully represent the in vivo structure of RNA? Modeling structure across different cellular contexts, such as in the presence of proteins or w/in macromolecular complexes would be a big boost & is an active area of research at Atomic. https://buff.ly/3R7XSYl

Unleash the future of medicine with Atomic AI 🚀🧪 Our interdisciplinary dream team merges RNA expertise, AI prowess & structural biology finesse. Together, we're breaking barriers and designing RNA-based medicines like never before. 💡💊 Join us: https://buff.ly/3MR6pfC

Only 2% 📉 of the genome is translated into proteins yet >80% 📈 is transcribed into RNA. We believe recent advances mean we can finally target these previously 'undruggable' RNA targets. Are you a scientist interested in exploring a new frontier? Join us: https://buff.ly/43nnfbA

R to @NFX: Blocked for advertising here. #riptwitter

Current methods for mapping RNA & its modifications -- the epitranscriptome -- are limited, with sequencing tech only able to detect a small # of these modifications. How could #AI help? Atomic founder Raphael Townshend provided insight to the @theNASEM https://www.ncbi.nlm.nih.gov/books/NBK593549/

🚀 On this #RNADay, let's celebrate the progress of RNA-based therapies and their potential to revolutionize medicine! 🩺 From mRNA vaccines to RNA interference, RNA is opening up new possibilities for treating diseases and improving lives. #RNARevolution

We believe that RNA 🧬 structure drives function. Solving RNA structures through our experimental biology and ML methods means we will better understand the biology that leads to disease. 🔎Learn more: https://atomic.ai 👩‍🔬Join us: https://atomic.ai/careers

R to @_brightscout: Side note: this is a concept and not the final version.

The power of technology taking the medical field to the next level. This is the concept we aimed to express when working for @AtomicAICo’s branding. Support it with a❤️‍🔥

We think that neither experimental biology nor AI methods are enough to solve the RNA structure problem. At Atomic AI we believe that advancements comes from scientists 👩‍🔬and engineers👷‍♀️in these fields working closely together. Join us: https://atomic.ai/careers